Drug Type Biosimilar, Colony-stimulating factors |
Synonyms Filgrastim Biosimilar (Curateq Biologics Pvt Ltd.), 非格司亭 生物类似药(Curateq Biologics Pvt Ltd.), BP 13 + [3] |
Target |
Action agonists |
Mechanism CSF-3R agonists(Colony stimulating factor 3 receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date European Union (12 Feb 2025), |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Neutropenia | European Union | 12 Feb 2025 | |
Neutropenia | Iceland | 12 Feb 2025 | |
Neutropenia | Liechtenstein | 12 Feb 2025 | |
Neutropenia | Norway | 12 Feb 2025 |